Diagnosis of human papillomavirus infection by abnormal cervical cytology is highly reproducible after vaginal douching

Taiwanese Journal of Obstetrics and Gynecology

Volumn 47, Issue 4, 2008, Pages 412-416

  Chen, Fang Chun ^a   Shaw, Sheng Wen ^b,c   Cheng, Po Jen ^b,c   Hsueh, Swei ^b   Lin, Cheng Tao ^b,c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Human papillomavirus; Papanicolaou smear; Vaginal douche

Indexed keywords

ACETIC ACID;

ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREDICTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINAL LAVAGE; VIRUS IDENTIFICATION; WART VIRUS;

EID: 59149095477     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60008-5     Document Type: Article

References (20)

1. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987;329:1247-9.
2. McGowan L. Peritonitis following the vaginal douche and a proposed alternative method for vaginal and vulvar care. Am J Obstet Gynecol 1965;93:506-9.
3. zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977;78:1-30.
4. Chua KL, Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 1997;66:108-13.
5. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
6. NIH releases consensus statement on cervical cancer. Am Fam Physician 1996;54:2310, 2315-6.
7. Baranovsky A, Myers MH. Cancer incidence and survival in patients 65 years of age and older. CA Cancer J Clin 1986;36: 26-41.
8. Harris R, Leininger L. Preventive care in rural primary care practice. Cancer 1993;72:1113-8.
9. Ponten J, Adami HO, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26.
10. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
11. Wright TC Jr, Richart RM. Role of human papillomavirus in the pathogenesis of genital tract warts and cancer. Gynecol Oncol 1990;37:151-64.
12. Schiffman MH, Kiviat NB, Burk RD, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 1995;33: 545-50.
13. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-10.
14. Hall S, Lorincz A, Shah F, et al. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecol Oncol 1996;62: 353-9.
15. Nindl I, Lorincz A, Mielzynska I, et al. Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 1998;10:49-56.
16. Levert M, Clavel C, Graesslin O, Masure M, Birembaut P, Quereux C, Gabriel R. Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients. Gynecol Obstet Fertil 2000;28:722-8. [In French]
17. Tseng CJ, Tseng LH, Lai CH, Soong YK, Hsueh S, Pao CC. Identification of human papillomavirus types 16 and 18 deoxyribonucleic acid sequences in bulky cervical cancer after chemotherapy. Am J Obstet Gynecol 1997;176:865-9.
18. Lin CT, Tseng CJ, Chou HH, Huang KG, Chang TC, Lai HH, Soong YK. High-risk human papillomavirus deoxyribonucleic acid as an adjunct marker in cervical cytology. Changgeng Yi Xue Za Zhi 1999;22:409-15.
19. Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang HJ, Law KS. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women ≥50 years of age. J Reprod Med 2000; 45: 345-50.
20. Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang KG, Huang HJ, Chao A. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 2001;184:940-5.